MVP
PFE icon

Missouri Valley Partners’s Pfizer PFE Stock Holding History

Missouri Valley Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$1.03M Sell
37,682
-853
-2% -$23.2K 0.39% 88
2013
Q2 		$1.02M Buy
+38,535
New +$1.06M 0.39% 78

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Missouri Valley Partners's PFE Position: Q3 2013 in Review

Missouri Valley Partners reduced its Pfizer (PFE) stake by 2.2% in Q3 2013, selling an estimated $23.2K and leaving 37,682 shares worth $1.03M. The position accounts for 0.39% of the portfolio, ranked #88.

Missouri Valley Partners first reported a position in PFE in Q2 2013 and has held it in 2 quarters since. 1,605 funds tracked by Wall St. Rank hold PFE as of Q3 2013.

  • Missouri Valley Partners held 37,682 shares of Pfizer worth $1.03M as of Q3 2013.
  • Missouri Valley Partners sold 853 Pfizer shares in Q3 2013, an estimated $23.2K.
  • Pfizer made up 0.39% of Missouri Valley Partners's portfolio in Q3 2013, its #88 holding.
  • Missouri Valley Partners first reported a position in Pfizer in Q2 2013 and has held it in 2 quarters since.
  • 1,605 funds tracked by Wall St. Rank held Pfizer as of Q3 2013.

Based on Missouri Valley Partners's 13F filing for Q3 2013, filed 13 Nov 2013.